-
Kenya's economy faces climate change risks: World Bank
-
China's rare earths El Dorado gives strategic edge
-
Wheelchair user flies into space, a first
-
French culture boss accused of mass drinks spiking to humiliate women
-
US Afghans in limbo after Washington soldier attack
-
Nasdaq rallies again while yen falls despite BOJ rate hike
-
US university killer's mystery motive sought after suicide
-
IMF approves $206 mn aid to Sri Lanka after Cyclone Ditwah
-
Rome to charge visitors for access to Trevi Fountain
-
Stocks advance with focus on central banks, tech
-
Norway crown princess likely to undergo lung transplant
-
France's budget hits snag in setback for embattled PM
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Trump signs $900 bn defense policy bill into law
-
EU-Mercosur deal delayed as farmers stage Brussels show of force
-
Harrison Ford to get lifetime acting award
-
Trump health chief seeks to bar trans youth from gender-affirming care
-
Argentine unions in the street over Milei labor reforms
-
Brazil open to EU-Mercosur deal delay as farmers protest in Brussels
-
Brussels farmer protest turns ugly as EU-Mercosur deal teeters
-
US accuses S. Africa of harassing US officials working with Afrikaners
-
ECB holds rates as Lagarde stresses heightened uncertainty
-
Trump Media announces merger with fusion power company
-
Stocks rise as US inflation cools, tech stocks bounce
-
Zelensky presses EU to tap Russian assets at crunch summit
-
Danish 'ghetto' residents upbeat after EU court ruling
-
ECB holds rates but debate swirls over future
-
Bank of England cuts interest rate after UK inflation slides
-
Have Iran's authorities given up on the mandatory hijab?
-
British energy giant BP extends shakeup with new CEO pick
-
EU kicks off crunch summit on Russian asset plan for Ukraine
-
Sri Lanka plans $1.6 bn in cyclone recovery spending in 2026
-
Most Asian markets track Wall St lower as AI fears mount
-
Danish 'ghetto' tenants hope for EU discrimination win
-
What to know about the EU-Mercosur deal
-
Trump vows economic boom, blames Biden in address to nation
-
ECB set to hold rates but debate swirls over future
-
EU holds crunch summit on Russian asset plan for Ukraine
-
Nasdaq tumbles on renewed angst over AI building boom
-
Billionaire Trump nominee confirmed to lead NASA amid Moon race
-
CNN's future unclear as Trump applies pressure
-
German MPs approve 50 bn euros in military purchases
-
EU's Mercosur trade deal hits French, Italian roadblock
-
Warner Bros rejects Paramount bid, sticks with Netflix
-
Crude prices surge after Trump orders Venezuela oil blockade
-
Warner Bros. Discovery rejects Paramount bid
E.coli can turn plastic into painkillers, chemists discover
Scientists have found a way to use the bacteria E.Coli to convert plastic waste into a popular painkiller, a study said Monday, though outside experts doubted the technique would make a dent in the fight against plastic pollution.
Paracetamol, which is one of the most commonly used drugs worldwide, is made from the derivatives of fossil fuels, often by Asia-based subcontractors using cheap, polluting methods that contribute to climate change.
The world is also facing an escalating crisis of plastic pollution, with countries set for another bruising round of negotiations in August in the hope of sealing an international treaty to reduce plastic waste.
The British team of researchers behind the new study sought to find a solution to the two problems by roping in a third -- E.coli, which is normally known for making people sick when they eat contaminated food.
First the chemists used a molecule derived from PET plastic, which is used in bottles and many other plastic products the world over, to spark a chemical reaction in a strain of E.coli.
This created a molecule they called PABA, according to the Nature Chemistry study, which was partly funded by drug firm AstraZeneca.
By genetically modifying the bacteria, the chemists were able to transform their molecule into acetaminophen, also known as paracetamol.
"This work demonstrates that PET plastic isn't just waste or a material destined to become more plastic -- it can be transformed by microorganisms into valuable new products, including those with potential for treating disease," lead study Stephen Wallace said in a statement.
Singaporean researchers not involved in the study praised how it combined synthetic and biological chemistry.
But "several practical considerations remain" to take this idea beyond the proof-of-concept stage, they wrote in a linked commentary in the journal Nature Chemistry.
The chemical reaction produces only a limited amount of PABA molecules, which "may be insufficient for industrial applications", they wrote.
Melissa Valliant, communications director of the Beyond Plastics project of Bennington College in the United States, expressed scepticism.
"A new 'plastic-eating bacteria' pops up in the news every few months and has been doing so for years," she told AFP.
"These discoveries never scale up to anything significant enough to tackle the massive plastic pollution problem."
This "crisis needs to be stopped at the source," she added, which means "companies and policymakers must reduce the amount of plastic being produced and used in the first place".
Y.Tengku--CPN